Page last updated: 2024-10-30

lansoprazole and Arrhythmia

lansoprazole has been researched along with Arrhythmia in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Research Excerpts

ExcerptRelevanceReference
"To compare lansoprazole with another proton pump inhibitor (PPI) during ceftriaxone treatment in terms of risk for ventricular arrhythmia, cardiac arrest, and in-hospital mortality."8.31Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole. ( Almufleh, A; Bai, AD; Rai, M; Razak, F; Srivastava, S; Verma, AA; Wilkinson, A, 2023)
"To compare lansoprazole with another proton pump inhibitor (PPI) during ceftriaxone treatment in terms of risk for ventricular arrhythmia, cardiac arrest, and in-hospital mortality."4.31Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole. ( Almufleh, A; Bai, AD; Rai, M; Razak, F; Srivastava, S; Verma, AA; Wilkinson, A, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bai, AD1
Wilkinson, A1
Almufleh, A1
Rai, M1
Razak, F1
Verma, AA1
Srivastava, S1
Wolfes, J1
Ellermann, C1
Burde, S1
Leitz, P1
Bögeholz, N1
Willy, K1
Fehr, M1
Eckardt, L1
Frommeyer, G1

Other Studies

2 other studies available for lansoprazole and Arrhythmia

ArticleYear
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole.
    JAMA network open, 2023, 10-02, Volume: 6, Issue:10

    Topics: Adult; Aged; Arrhythmias, Cardiac; Ceftriaxone; Cohort Studies; Female; Heart Arrest; Humans; Inpati

2023
Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts.
    Cardiovascular toxicology, 2020, Volume: 20, Issue:6

    Topics: Action Potentials; Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial;

2020